Ivermectin tablets to be distributed among Uttarakhand residents to prevent Covid, says state govt

The Uttarakhand government will be distributing Ivermectin, an antiparasitic drug, among the residents of the state as a preventive medicine against the spread of Covid-19, a senior official said.

The Uttarakhand government’s announcement comes after Goa and Karnataka issued similar directions.

The decision was taken on the recommendation of the state-level clinical technical committee, an order issued by Chief Secretary Om Prakash to all district magistrates said.

ALSO READ: Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?

The panel has recommended the Ivermectin tablet as “mass chemoprophylaxis” to effectively control the surge of Covid-19 infection apart from the vaccination drive, the order said.

The 12 mg tablets of the drug will be distributed in a kit to all families through the health department and district magistrates, the order said.

Dosage

Usually, Ivermectin tablets have to be taken by adults and those above 15 years twice daily for three days after breakfast and dinner. One person will thus need six tablets and a family of four will need 24 tablets. Hence, each kit will contain two dozen tablets, the order said.

Children between 10-15 years will take only one tablet daily whereas those aged between 2 and 10 years can be administered the drug only after doctor's advice. The tablet cannot be given to children below two years, pregnant women and those suffering from liver diseases, it said.

The kit will come with directions on how to consume the medicine and dosage for different age groups. Information related to the daily distribution of the kits should be sent to the state nodal officer, the order said.

Goa

Goa Health Minister Vishwajit Rane had on Monday said all people above 18 years will be given Ivermectin drug irrespective of their coronavirus status to bring down the number of deaths due to the viral disease.

In our efforts to reduce Covid-19 severity in the state we shall soon start the prophylaxis treatment with Ivermectin for covid patients who are of the 18+ age group. This will help us in reducing the mortality rate too & speed up the recovery process of patients. pic.twitter.com/wPJ35td4dy — VishwajitRane (@visrane) May 11, 2021

Rane had said that people will be given Ivermectin 12 mg for five days as expert panels from the UK, Italy, Spain and Japan have found a statistically significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with this medicine.

Karnataka

On Tuesday, Karnataka Deputy Chief Minister and state's Covid task force head C N Ashwath Narayan said 10 lakh Ivermectin tablets have been procured and their supply will begin on May 14.

It has been further decided to procure 25 lakh tablets and make them available in all hospitals across the state, he said.

Medical experts, however, have questioned the efficacy of the five-day duration of the drug regimen announced by Goa government saying the treatment should not be given for a short period but ideally be continued till the pandemic is brought under control.

WHO's warning

Meanwhile, the World Health Organisation has warned against the use of Ivermectin to treat COVID-19.

“Safety and efficacy are important when using any drug for a new indication. @WHO recommends against the use of ivermectin for #COVID19 except within clinical trials,” Soumya Swaminathan, WHO Chief Scientist said in a tweet on Tuesday. However, regular use of the oral antiparasitic drug may significantly reduce the risk of contracting COVID-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.

Safety and efficacy are important when using any drug for a new indication. @WHO recommends against the use of ivermectin for #COVID19 except within clinical trials https://t.co/dSbDiW5tCW — Soumya Swaminathan (@doctorsoumya) May 10, 2021

The research, published in the May-June issue of the American Journal of Therapeutics, is the most comprehensive review of the available data on Ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said.

ALSO READ: Have questions on Covid-19 treatment? Group of doctors answers them here